Suppr超能文献

多巴胺调节障碍综合征的识别与挑战:一例报告

The Identification and Challenges of Dopamine Dysregulation Syndrome: A Case Report.

作者信息

Sulaiman Andrew, Leppla Idris

机构信息

Psychiatry, Johns Hopkins University, Baltimore, USA.

出版信息

Cureus. 2025 Jun 22;17(6):e86547. doi: 10.7759/cureus.86547. eCollection 2025 Jun.

Abstract

A 48-year-old man with a history of opioid use disorder (unmanaged) and presumed Parkinson's disease presented to the emergency department secondary to worsening of his Parkinson's tremors/ambulatory dysfunction. He expressed that he was taking up to 20 doses of his carbidopa/levodopa (25mg-250mg pills for a total of >5g levodopa every day). The patient was admitted for the management of Parkinson's tremors and substance abuse. He was administered carbidopa/levodopa (25mg-250mg) every eight hours. Psychiatry was consulted due to marked functional fluctuations in his presentation and found that he demonstrated positive choreiform movements of the head/neck and upper extremity after taking the carbidopa. The patient's presentation prompted a suspicion of dopamine dysregulation syndrome (DDS). Supporting evidence included that the patient was insistent that the current regimen of carbidopa/levodopa wasn't managing symptoms, and even when the frequency was increased to every six hours, the patient expressed that his symptoms were still present and problematic. The patient stated that if the carbidopa/levodopa dosage wasn't further increased, he would leave the hospital. He ended up leaving against medical advice and was later ultimately re-admitted with the goal of transitioning to a rehabilitation facility for the treatment optimization of his substance use disorder and Parkinson's disease. This case demonstrates the challenges and presentation of DDS. DDS is a disorder marked by compulsive overuse of dopaminergic medication, which frequently occurs in individuals with Parkinson's disease. Additionally, this case reviews diagnostic criteria and moreover summarizes literature supporting methods of clinical management.

摘要

一名48岁男性,有阿片类药物使用障碍病史(未得到控制),并被推测患有帕金森病,因帕金森震颤/行走功能障碍恶化而就诊于急诊科。他表示自己每天服用多达20剂卡比多巴/左旋多巴(25毫克 - 250毫克片剂,左旋多巴总量>5克)。患者因帕金森震颤和药物滥用问题入院治疗。每八小时给他服用一次卡比多巴/左旋多巴(25毫克 - 250毫克)。由于其临床表现存在明显的功能波动,于是咨询了精神科,结果发现他在服用卡比多巴后出现了头部/颈部和上肢的阳性舞蹈样动作。患者的表现引发了对多巴胺调节障碍综合征(DDS)的怀疑。支持证据包括患者坚持认为目前的卡比多巴/左旋多巴治疗方案无法控制症状,即使服药频率增加到每六小时一次,患者仍表示症状依然存在且很严重。患者称如果不进一步增加卡比多巴/左旋多巴的剂量,他就会出院。他最终不听从医嘱自行出院,后来又再次入院,目的是转至康复机构,以优化其药物使用障碍和帕金森病的治疗。该病例展示了DDS的挑战和临床表现。DDS是一种以多巴胺能药物强迫性过度使用为特征的疾病,常见于帕金森病患者。此外,该病例回顾了诊断标准,并总结了支持临床管理方法的文献。

相似文献

1
The Identification and Challenges of Dopamine Dysregulation Syndrome: A Case Report.
Cureus. 2025 Jun 22;17(6):e86547. doi: 10.7759/cureus.86547. eCollection 2025 Jun.
6
Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.
Cochrane Database Syst Rev. 2022 May 20;5(5):CD013665. doi: 10.1002/14651858.CD013665.pub3.
8
Ropinirole for levodopa-induced complications in Parkinson's disease.
Cochrane Database Syst Rev. 2001(1):CD001516. doi: 10.1002/14651858.CD001516.
9
Sertindole for schizophrenia.
Cochrane Database Syst Rev. 2005 Jul 20;2005(3):CD001715. doi: 10.1002/14651858.CD001715.pub2.
10
Bromocriptine versus levodopa in early Parkinson's disease.
Cochrane Database Syst Rev. 2000(3):CD002258. doi: 10.1002/14651858.CD002258.

本文引用的文献

1
New pharmacological and neuromodulation approaches for impulsive-compulsive behaviors in Parkinson's disease.
Neurol Sci. 2021 Jul;42(7):2673-2682. doi: 10.1007/s10072-021-05237-8. Epub 2021 Apr 14.
2
Dopamine dysregulation syndrome in non-Parkinson's disease patients: a systematic review.
Australas Psychiatry. 2019 Oct;27(5):456-461. doi: 10.1177/1039856219839476. Epub 2019 Apr 29.
3
Dopamine dysregulation syndrome in Parkinson's disease: a systematic review of published cases.
J Neurol Neurosurg Psychiatry. 2017 Dec;88(12):1060-1064. doi: 10.1136/jnnp-2017-315985. Epub 2017 Oct 10.
4
Successful treatment of dopamine dysregulation syndrome with valproic acid.
J Neuropsychiatry Clin Neurosci. 2014 Summer;26(3):E3. doi: 10.1176/appi.neuropsych.13060126.
5
Dopamine dysregulation syndrome in Parkinson's disease: from clinical and neuropsychological characterisation to management and long-term outcome.
J Neurol Neurosurg Psychiatry. 2014 Mar;85(3):311-8. doi: 10.1136/jnnp-2012-303988. Epub 2013 Apr 16.
6
Valproate as a treatment for dopamine dysregulation syndrome (DDS) in Parkinson's disease.
J Neurol. 2013 Feb;260(2):521-7. doi: 10.1007/s00415-012-6669-1. Epub 2012 Sep 25.
7
Compulsive use of dopaminergic drug therapy in Parkinson's disease: reward and anti-reward.
Mov Disord. 2010 May 15;25(7):867-76. doi: 10.1002/mds.22898.
8
Dopamine dysregulation syndrome: an overview of its epidemiology, mechanisms and management.
CNS Drugs. 2009;23(2):157-70. doi: 10.2165/00023210-200923020-00005.
9
Compulsive use of dopamine replacement therapy in Parkinson's disease: reward systems gone awry?
Lancet Neurol. 2003 Oct;2(10):595-604. doi: 10.1016/s1474-4422(03)00529-5.
10
Hedonistic homeostatic dysregulation in patients with Parkinson's disease on dopamine replacement therapies.
J Neurol Neurosurg Psychiatry. 2000 Apr;68(4):423-8. doi: 10.1136/jnnp.68.4.423.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验